Erasca
eras significantly extends survival at clinically relevant exposures in an amplified and model vehicle treatment days | Erasca
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
39 of 56
Similar slides by Erasca
See diffirences between slides (animation)
Investor Presentation
January 2024
eras significantly extends survival at clinically relevant exposures in an amplified and model treatment day | Erasca
Investor Presentation
November 2023
eras significantly extends survival at clinically relevant exposures in an amplified and model treatment days | Erasca
Related slides by other companies
Chimerix
Results
March 2022
treatment initiated post infection significantly improved titers and lung pathology at day | Chimerix
Enochian Biosciences
Investor Presentation
January 2024
| Enochian Biosciences
Kaia Health
Start Up
April 2021
all secondary outcomes are significantly better for than for standard of care treatments | Kaia Health
Enochian Biosciences
Investor Presentation
October 2022
control of without antiviral treatment for days a lower level of virus than when with antiviral treatment | Enochian Biosciences
Other recent decks by Erasca
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
IPO
July 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io